Literature DB >> 1294395

Case-control study of congenital malformations.

J Ananijevic-Pandey1, M Jarebinski, B Kastratovic, H Vlajinac, Z Radojkovic, D Brankovic.   

Abstract

To determine potentially teratogenic influences in Belgrade, a group of 113 mothers who gave birth to severely malformed infants and a control group of 195 mothers with normal infants were interviewed using a structured questionnaire. Statistically significant differences between the two groups were found in the mother's family history of congenital malformations (P < 0.05) and the mother's diseases during the pregnancy (P < 0.01). Infections in the first trimester were particularly more prevalent in case mothers (OR = 7.70; P < 0.01). Mothers did not differ significantly according to exposure to organic solvents, supportive therapy during the pregnancy, use of oral contraceptives, or other personal habits.

Entities:  

Mesh:

Year:  1992        PMID: 1294395     DOI: 10.1007/bf00145335

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  4 in total

Review 1.  Epidemiology of birth defects.

Authors:  M J Khoury
Journal:  Epidemiol Rev       Date:  1989       Impact factor: 6.222

2.  Statistical methods in cancer research. Volume I - The analysis of case-control studies.

Authors:  N E Breslow; N E Day
Journal:  IARC Sci Publ       Date:  1980

3.  Exogenous hormones and other drug exposures of children with congenital heart disease.

Authors:  K J Rothman; D C Fyler; A Goldblatt; M B Kreidberg
Journal:  Am J Epidemiol       Date:  1979-04       Impact factor: 4.897

Review 4.  Perinatal morbidity in Belgium.

Authors:  R Lagasse; H Devlieger; P De Wals; P Casaer; E Eggermont; M F Lechat
Journal:  Biol Neonate       Date:  1989
  4 in total
  1 in total

Review 1.  Maternal smoking in pregnancy and birth defects: a systematic review based on 173 687 malformed cases and 11.7 million controls.

Authors:  Allan Hackshaw; Charles Rodeck; Sadie Boniface
Journal:  Hum Reprod Update       Date:  2011-07-11       Impact factor: 15.610

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.